Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M561Revenue (TTM) $M15.0Net Margin (%)-452.4Altman Z-Score19.6
Enterprise Value $M211EPS (TTM) $-0.5Operating Margin %-477.3Piotroski F-Score1
P/E(ttm)--Beneish M-Score32.3Pre-tax Margin (%)-452.4Higher ROA y-yN
Price/Book1.610-y EBITDA Growth Rate %-25.6Quick Ratio25.3Cash flow > EarningsY
Price/Sales37.35-y EBITDA Growth Rate %-26.5Current Ratio25.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-1,056.9ROA % (ttm)-16.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-17.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M137ROIC % (ttm)-898.0Gross Margin Increase y-yN

Gurus Latest Trades with ACHN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ACHN is held by these investors:



ACHN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FISHERMAN JASON SDirector 2016-12-22Buy10,000$3.963.54view
Fenton Mary KayCFO 2016-12-05Buy2,500$4.11-0.24view
Truitt JosephChief Commercial Officer 2016-12-02Buy3,500$4.060.99view
MANNING MARTHA EEVP, General Counsel 2016-12-02Buy2,500$4.090.24view
Deshpande MilindCEO 2016-12-02Buy2,500$4.060.99view
Barrish Joel CChief Scientific Officer 2016-12-02Buy2,500$4.060.99view
Apelian DavidChief Medical Officer 2015-12-30Sell10,000$10.5-60.95view
Fenton Mary KayCFO 2015-12-28Sell43,500$10.08-59.33view
VITULLO NICOLEDirector 2015-11-11Sell550,000$10.17-59.69view
VITULLO NICOLEDirector 2015-09-25Sell9,310$8.22-50.12view

Press Releases about ACHN :

Quarterly/Annual Reports about ACHN:

News about ACHN:

Articles On GuruFocus.com
Achillion to Present at the 2017 Leerink Partners Rare Disease Roundtable Series Sep 20 2017 
Achillion Announces Termination of Worldwide Collaboration for Hepatitis C With Janssen Sep 11 2017 
Achillion Announces Strengthening of Management Team Sep 11 2017 
Achillion Pharmaceuticals, Fossil Move Drastically on Earnings Reports Aug 09 2017 
Achillion to Host Second Quarter 2017 Results Conference Call on August 8, 2017 Aug 01 2017 
Achillion Pharmaceutials Announces Key Promotion and Discovery Organization Change Jul 10 2017 
Achillion to Present at the 2017 JMP Securities Life Sciences Conference Jun 15 2017 
Achillion to Present at the Jefferies 2017 Global Healthcare Conference Jun 05 2017 
Achillion Reports First Quarter 2017 Financial Results and Provides Update on Clinical Programs May 04 2017 
Achillion to Present at the Deutsche Bank 42nd Annual Health Care Conference May 02 2017 

More From Other Websites
Achillion to Present at the 2017 Leerink Partners Rare Disease Roundtable Series Sep 20 2017
Pharma Stock Roundup: Achillion Slumps on End of HCV Deal, Teva Gets a New CEO Sep 15 2017
Achillion's HCV Partnership with J&J Terminated, Stock Falls Sep 12 2017
Achillion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACHN-US :... Sep 12 2017
Today's Research Reports on Stocks to Watch: Achillion Pharmaceuticals and Idera Pharmaceuticals Sep 12 2017
Why Achillion Pharmaceuticals Crashed 22.2% Today Sep 11 2017
Achillion Shares Are Plunging on Termination of Hepatitis C Pact Sep 11 2017
Achillion Pharma Slides After Hep C Deal Is Terminated Sep 11 2017
Achillion Pharmaceuticals falls 25% after hepatitis C deal with J&J unit ends Sep 11 2017
Achillion Announces Strengthening of Management Team Sep 11 2017
Achillion Announces Termination of Worldwide Collaboration for Hepatitis C With Janssen Sep 11 2017
Edited Transcript of ACHN earnings conference call or presentation 8-Aug-17 8:05pm GMT Aug 16 2017
Corporate News Blog - Achillion Announces Proof-of-Concept with a First-in-Class, Oral Factor D... Aug 11 2017
Achillion Pharmaceuticals Stock Falls, Baird Downgrades Over Lack of Confidence Aug 10 2017
Achillion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACHN-US :... Aug 10 2017
Today's Research Reports on Stocks to Watch: Achillion Pharmaceuticals and ACADIA Pharmaceuticals Aug 10 2017
2 Reasons Behind Achillion Pharmaceuticals, Inc.'s 11% Tumble in July Aug 09 2017
Why Achillion Pharmaceuticals Is Shooting 25% Higher Today Aug 09 2017
These Two Biotech Stocks Are Going Berserk on Wednesday Aug 09 2017
3 Biotech Stocks Under the Microscope on Wednesday 8/9/17 Aug 09 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}